Form 4: Fulgent Genetics CEO Reports Routine Stock Dispositions for Tax Obligations
Insider Transaction Report
Fulgent Genetics, Inc. CEO Ming Hsieh reported the disposition of 5,060 shares of common stock to cover tax withholding obligations related to the vesting of restricted stock units.
Summary
- Ming Hsieh, Chief Executive Officer, Director, and 10% Owner of Fulgent Genetics, Inc. (FLGT), reported transactions involving the company's common stock.
- On May 23, 2025, Mr. Hsieh disposed of 2,116 shares of common stock at a price of $20.31 per share.
- On May 26, 2025, an additional 2,944 shares of common stock were disposed of, also at $20.31 per share.
- These dispositions, totaling 5,060 shares, were non-discretionary transactions to satisfy tax withholding obligations arising from the vesting of restricted stock units (RSUs).
- The RSUs that vested were granted on February 23, 2023, and February 26, 2024.
- Following these transactions, Mr. Hsieh directly beneficially owns 810,679 shares of common stock.
- Additionally, Mr. Hsieh indirectly beneficially owns 220,816 shares through the Dynasty Trust, 7,895,115 shares through The Ming Hsieh Trust, and 2,000 shares through Uniform Transfer to Minor Accounts, bringing his total beneficial ownership to 8,928,610 shares.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing reports a routine, non-discretionary transaction (shares withheld for tax obligations upon RSU vesting) which is a common occurrence for executives receiving equity compensation and does not indicate a change in company performance or outlook.
Industry Context
This Form 4 filing is a routine disclosure of an insider transaction, specifically the disposition of shares to cover tax liabilities upon the vesting of restricted stock units. Such transactions are common across all industries for executives receiving equity compensation and do not typically reflect a change in strategic outlook or operational performance.
Related Party Transactions
- Ming Hsieh's beneficial ownership includes shares held indirectly through the Dynasty Trust, The Ming Hsieh Trust, and Uniform Transfer to Minor Accounts, where he has varying degrees of control or influence.
Stakeholder Impact
- Shareholders: Minimal direct impact as these are routine tax-related dispositions and not a discretionary sale by the CEO. The CEO retains substantial beneficial ownership.
- Employees: No direct impact indicated by this filing.
- Customers: No direct impact indicated by this filing.
- Suppliers: No direct impact indicated by this filing.
- Creditors: No direct impact indicated by this filing.
Key Dates
| Date | Description |
|---|---|
| 02/23/2023 | Grant date of certain restricted stock units to the reporting person. |
| 02/26/2024 | Grant date of certain restricted stock units to the reporting person. |
| 05/23/2025 | Transaction date for disposition of 2,116 shares to satisfy tax withholding obligations. |
| 05/26/2025 | Transaction date for disposition of 2,944 shares to satisfy tax withholding obligations. |
| 05/28/2025 | Date the Form 4 filing was signed. |
Keywords
Fulgent Genetics, FLGT, Ming Hsieh, Form 4, Insider Transaction, Stock Ownership, CEO, Restricted Stock Units, Tax Withholding
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.